Cargando…

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.

The influence of the prototype aromatase inhibitor Aminoglutethimide (AG) and its analogue Rogletimide (RG) on peripheral aromatisation were investigated in 13 postmenopausal women with advanced breast cancer. Seven patients received AG 1,000 mg daily plus Hydrocortisone (HC) cover and six received...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacNeill, F. A., Jones, A. L., Jacobs, S., Lønning, P. E., Powles, T. J., Dowsett, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977412/ https://www.ncbi.nlm.nih.gov/pubmed/1419608

Ejemplares similares

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
por: Lønning, P. E., et al.
Publicado: (1991)

Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
por: MacNeill, F. A., et al.
Publicado: (1994)

Role of aminoglutethimide in male breast cancer.
por: Harris, A. L., et al.
Publicado: (1986)

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.
por: Geisler, J., et al.
Publicado: (1996)

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
por: Harris, A. L., et al.
Publicado: (1986)

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Aromatisation of steroids in the bivalve Mytilus trossulus
por: Hallmann, Anna, et al.
Publicado: (2019)

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
por: Ponder, B. A., et al.
Publicado: (1984)

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
por: Coombes, R. C., et al.
Publicado: (1982)

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1991)

Polymorphically acetylated aminoglutethimide in humans.
por: Coombes, R. C., et al.
Publicado: (1982)

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
por: Dowsett, M., et al.
Publicado: (1988)

Effect of rapeseed oil aromatisation with marjoram on the content of volatile fraction and antioxidant properties
por: Kowalski, Radosław, et al.
Publicado: (2019)

Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.
por: Stuart-Harris, R., et al.
Publicado: (1985)

Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.
por: Williams, C. J., et al.
Publicado: (1993)

Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
por: Goss, P. E., et al.
Publicado: (1985)

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.
por: LÃ¸nning, P. E., et al.
Publicado: (1989)

Complexes With Biologically Active Ligands. Part 2. Preparation of Copper(II) Complexes of Positively-Charged Derivatives of Aminoglutethimide
por: Supuran, Claudiu T.
Publicado: (1996)

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
por: Pfeiler, G, et al.
Publicado: (2013)

Synthesis and Characterization of an Inclusion Complex of dl-Aminoglutethimide with β-Cyclodextrin and Its Innovative Application in a Biological System: Computational and Experimental Investigations
por: Ray, Samapika, et al.
Publicado: (2022)

Treatment of breast cancer with aromatase inhibitors--current status and future prospects.
por: LÃ¸nning, P. E., et al.
Publicado: (1989)

Correction to “Synthesis and Characterization of an Inclusion Complex of dl-Aminoglutethimide with β-Cyclodextrin and Its Innovative Application in a Biological System: Computational and Experimental Investigations”
por: Ray, Samapika, et al.
Publicado: (2022)

Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
por: Leal, Mariana Ferreira, et al.
Publicado: (2019)

Chronic breast abscess due to Mycobacterium fortuitum: a case report
por: Betal, Dibendu, et al.
Publicado: (2011)

In vitro osteolytic activity of human breast carcinoma tissue and prognosis.
por: Dady, P. J., et al.
Publicado: (1981)

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
por: Pinhel, Isabel F, et al.
Publicado: (2010)

Rationalizing breast cancer surgery during the COVID-19 pandemic
por: Tasoulis, Marios-Konstantinos, et al.
Publicado: (2020)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

Effects of endocrine therapy on steroid-receptor content of breast cancer.
por: Taylor, R. E., et al.
Publicado: (1982)

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
por: Pierga, J-Y, et al.
Publicado: (2007)

LHRH analogues and breast cancer.
por: Korkut, E., et al.
Publicado: (1991)

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1996)

Identification of a Candidate Rad1 Subunit for the Kinetoplastid 9-1-1 (Rad9-Hus1-Rad1) Complex
por: MacNeill, Stuart A.
Publicado: (2014)

PCNA-binding proteins in the archaea: novel functionality beyond the conserved core
por: MacNeill, Stuart A.
Publicado: (2016)

Remote Homology Detection Identifies a Eukaryotic RPA DBD-C-like DNA Binding Domain as a Conserved Feature of Archaeal Rpa1-Like Proteins
por: MacNeill, Stuart A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vv2gl24n3ufvtkrk1kte3o7hlt